Author:
Kim Jee Hyun,Park Jong Beak,Bae Pan Kee,Kim Hae Soo,Kim Do Wan,Ahn Jeong Keun,Lee Chong-Kyo
Reference40 articles.
1. Establishment of mutant FM3A murine mammary carcinoma cell strains transformed with the herpes simplex virus type 1 thymidine kinase gene;Ayusawa;Jpn. J. Cancer Res. (Gann),1985
2. Inhibitory effects of (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU) and related compounds on herpes simplex virus (HSV)-infected cells and HSV thymidine kinase gene-transformed cells;Balzarini;Methods Find. Exp. Clin. Pharmacol.,1989
3. Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2′-deoxyuridine and related compounds;Balzarini;FEBS Lett.,1985
4. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2′-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene;Balzarini;Mol. Pharmacol.,1985
5. Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2′-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)-guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2;Balzarini;J. Biol. Chem.,1993
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献